410571 Membrane Enhanced Peptide Synthesis (MEPS) Integrating Organic Solvent Nanofiltration (OSN) into Iterative Chemical Reactions

Wednesday, November 11, 2015: 1:12 PM
Salon I (Salt Lake Marriott Downtown at City Creek)
Wenqian Chen1, Juergen Riegler2, Michele Cristau2 and Andrew G. Livingston1, (1)Chemical Engineering, Imperial College London, London, United Kingdom, (2)Lonza AG, Visp, Switzerland

In the pharmaceutical industry, the high potency and specificity of peptides make them more attractive than traditional small-molecule drugs. The chemical synthesis of peptides involves the repetitive addition of amino acid, in between which the intermediate products have to be isolated for purification purposes. It is of paramount importance to achieve high yield for the isolation of each intermediate product or the cumulative mass loss will be detrimental to overall yield of the synthesis. The conventional peptide synthesis methods, namely Liquid Phase Peptide Synthesis (LPPS) and Solid Phase Peptide Synthesis (SPPS), have been used in the industry over the past few decades, but innovation is still required to improve process performance. Membrane Enhanced Peptide Synthesis (MEPS) integrates Organic Solvent Nanofiltration (OSN) into LPPS. A hexapeptide (Pyr-Ser(Bzl)-Ala-Phe-Asp-Leu-NH2) was synthesised successfully via MEPS at a scale of 33.65 mmol and a soluble anchor concentration of 10.4 wt% in the starting solution. Before the cleavage and global deprotection of peptide, MEPS achieved a high purity (88.1%) and a decent overall yield (71.2%), similar to LPPS (100.0% and 72.4% respectively), in which the intermediate products were precipitated and purified. Consequently, the performance of MEPS was better than LPPS in terms of material cost, process time, volumetric efficiency and E-factor, showing that OSN is indeed a more attractive option than precipitation for the isolation of intermediate products in liquid phase iterative chemical reactions.

Extended Abstract: File Not Uploaded
See more of this Session: Pharmaceutical Process Development and Pilot Plants
See more of this Group/Topical: Process Development Division